Micro Syringes Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Micro Syringes Market in 2025 is evaluated at USD 360.47 million. The global market size exceeded USD 341.87 million in 2024 and is projected to expand at a CAGR of more than 6.8%, crossing USD 804.06 million by 2037. North America is expected to grow to USD 281.42 million by 2037, fueled by the U.S.'s dominance in pharmaceutical spending and rising R&D activities.
The uptrend demand for microliter syringes for precise drug delivery will propel the market growth. Micro syringes are used to inject fluids into the patients and draw fluid from their bodies.
Furthermore, with greater emphasis on the bio revolution and the elevated volume of life science research investigations taking place globally, the market for assistive medical tools, including micro syringes is anticipated to expand to back such research and revolution.
Micro Syringes Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Number of Preclinical, and Clinical Trials – The need to figure out the efficacy of drug discovery and micro syringe treatment is responsible for the surging number of clinical trials. World Health Organization (WHO), has registered 157,618 trials during 1999-2021 in the United States of America.
- Growing Pharmaceutical & Biopharmaceuticals Industry – Incessant research to develop new drugs and drug delivery systems in the pharmaceutical industry is set to augment the demand for micro syringes in the upcoming years. Micro syringes have shown profound promise in biopharmaceutical, and biomedical applications.
- Increasing Demand for Minimally Invasive Procedures – The rising popularity of minimally invasive cosmetic surgery procedures worldwide with the astounding surge in the volume of cosmetic and aesthetic treatments via injection will impel the micro syringes market revenue.
- Scaling Up Doses of Vaccination – Expanding vaccine industry and the rising focus of governments to act on immunization plans is driving the demand of micro syringes. About 16 billion vaccine doses were supplied globally in 2021, 3 times the 2019 market volume.
Challenges
- Dearth of Skilled Professionals – Micro syringes are generally utilized by patients who have received special training as they cannot be easily used. Hence, the lack of trained personnel who monitor on correct injection method, safe needle disposal, and other issues are hindering the penetration of such syringes for mass utilization.
- Stringent guidelines for the use of safety-engineered syringes
- High cost of production
Micro Syringes Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.8% |
|
Base Year Market Size (2024) |
USD 341.87 million |
|
Forecast Year Market Size (2037) |
USD 804.06 million |
|
Regional Scope |
|
Micro Syringes Segmentation
Needle Type (Fixed, Removable)
The removable sub-segment in the needle type segment is predicted to dominate over 65% market share by the end of 2037. Removable needles are reusable in nature and it is available in different sizes. They are also available in different customizations and different point styles. Owing to all such qualities, they are widely preferred by inexperienced users.
End-User (Biotechnological Laboratories, Biotechnological & Pharmaceutical Industry, Research Institutes, Hospitals)
The laboratories segment with a share of 35% is poised to lead the market of micro syringes by 2037. This is attributed to the increasing laboratory research activities throughout the globe and the increasing usage of micro syringes in laboratories for drawing up and expelling liquids or suspensions facilitating such research works.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Needle Type |
|
|
End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Micro Syringes Industry - Regional Synopsis
North American Market Forecast
North America industry is estimated to hold largest revenue share of 35% by 2037. United States with the largest national pharmaceutical market with almost 41% of total global pharmaceutical spending in 2021 is responsible for the fast pace growth of the market in the region.
The increasing collaboration activities between pharma companies and research institutes for the development of novel drugs will also boost the market expansion. The rising investments in R&D in the analytical techniques for the accurate detection of proteins are also responsible for the growing demand for micro syringes in the pharmaceutical sector.
Europe Market Forecast
Europe micro syringes market will be the second largest, registering a share of about 25% by the end of 2037. The advancement in the healthcare and biomedical research sector in the region is boosting the adoption of several advanced technologies in analytical chemistry.
One such technique is the chromatography technique where the micro syringes function primarily as a pipette or liquid-transfer device that loads a sample loop in high-pressure liquid chromatography (HPLC). It analyzes complex biological fluids like blood, plasma, and serum, aiding the development of targeted precision medicines.
Companies Dominating the Micro Syringes Landscape
- Trajan Scientific and Medical
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.
- Innovative Labor Systeme GmbH (ILS)
- GL Science, Inc.
- PerkinElmer, Inc.
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Avantor, Inc.
- ITO Corporation
- Merck KGaA
Recent Developments
- Trajan Scientific and Medical completed the acquisition of Neoteryx LLC, a leader in blood micro-sampling devices. This acquisition will drive the global commercialization and adoption of micro-sampling at a large scale for Trajan.
- Thermo Fisher Scientific Inc. acquired the leading global provider of clinical research services, PPD, Inc. for USD 17.4 billion.
- Report ID: 3989
- Published Date: Apr 18, 2025
- Report Format: PDF, PPT
Have specific data needs or budget constraints?
Reach out to us for a customized quote or to learn more about our special pricing
for startups and universities
Frequently Asked Questions (FAQ)
Micro Syringes Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
